Alantra acts as Ferrer’s sole financial advisor on Spain’s first sustainable financing agreement
Value €220 million
Madrid – Alantra, a global investment bank and asset management firm, has acted as sole financial advisor to Grupo Ferrer Internacional, S.A. (“Ferrer”), a leading pharmaceutical and chemicals company, on Spain’s first sustainable financing agreed by a pharmaceutical company consisting of a loan of €220 million. The conditions of the refinancing agreement are linked to social and environmental sustainability criteria.
Founded in Barcelona in 1959, Ferrer is present in more than one hundred countries and has a team of 2,000 professionals across the globe. The firm provides trusted solutions through incremental and focussed innovation in the areas of pain, nervous system and self-care. Across all its activity, Ferrer aims to achieve sustainable growth, reducing Co2 emissions, improving waste management and expanding training to its employees; positive results for these indicators will reduce the loan interest rate.
The financing, signed with BBVA and CaixaBank, is divided into three tranches: Term Loan, Revolving Credit Facility (current line) and Capex Line (line of credit for acquisitions), with a term of 6 years.
David Ferrer, Chief Financial & Corporate Services Officer of Grupo Ferrer explained: “At Ferrer we understand sustainability as a central and transversal axis of all our activity: any action must respond to goals of people’s improvement, the planet and the local community. This funding agreement shows our commitment to the desire of making a positive impact on our environment.”
Javier García-Palencia, Managing Partner and Head of Debt Capital Markets & Debt Advisory at Alantra, said: “We are delighted to sign such a significant deal for the pharmaceutical sector and Alantra’s debt advisory practice in Spain. This financing supports Grupo Ferrer’s strategy of sustainable growth and supports its promotion of a better society and the well-being of people.”
Dec 2021Growth investmentDec 2021SECTOR HealthcareService Strategic Advisory
Dec 2021Debt Capital MarketsValue €230 millionDec 2021SECTOR HealthcareService Debt AdvisoryValue €230 million
Nov 2021Private placement and Equity raisingNov 2021SECTOR HealthcareService Equity Capital Markets
Nov 2021Sell-side advisoryValue $47.4 millionNov 2021SECTOR HealthcareService M&AValue $47.4 million